(Q44432097)

2 December 2017

Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer (English)

1 reference

2 December 2017

Multiplex Biomarker Approach for Determining Risk of Prostate-Specific Antigen-Defined Recurrence of Prostate Cancer (English)

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

31 December 2023

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

31 December 2023

author name string

Daniel R. Rhodes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734317

31 December 2023

Martin G. Sanda

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734317

31 December 2023

Arie P. Otte

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734317

31 December 2023

Arul M. Chinnaiyan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734317

31 December 2023

Mark A. Rubin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734317

31 December 2023

language of work or name

English

0 references

publication date

1 May 2003

1 reference

2 December 2017

7 May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12734317

Journal of the National Cancer Institute

31 December 2023

published in

1 reference

2 December 2017

95

1 reference

2 December 2017

661-668

1 reference

2 December 2017

9

1 reference

Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends

2 December 2017

2

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience

31 December 2023

4

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer

31 December 2023

5

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.

31 December 2023

6

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer

31 December 2023

7

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

A catalog of prostate cancer nomograms

31 December 2023

8

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

31 December 2023

10

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

31 December 2023

11

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification

31 December 2023

12

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

Molecular portraits of human breast tumours

31 December 2023

13

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

Delineation of prognostic biomarkers in prostate cancer

31 December 2023

16

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

Gene expression correlates of clinical prostate cancer behavior

31 December 2023

17

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

Gene expression analysis of prostate cancers

31 December 2023

19

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer

31 December 2023

21

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

The polycomb group protein EZH2 is involved in progression of prostate cancer

31 December 2023

22

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model

31 December 2023

23

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

Natural history of progression after PSA elevation following radical prostatectomy

31 December 2023

24

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

Cancer chemotherapy reports

31 December 2023

25

50

125

Gleason

1966

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.

31 December 2023

26

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

Tissue microarrays for high-throughput molecular profiling of tumor specimens

31 December 2023

28

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

Biological determinants of cancer progression in men with prostate cancer.

31 December 2023

29

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

Prostate cancer involving the bladder neck: recurrence-free survival and implications for AJCC staging modification

31 December 2023

30

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

A comparison of test statistics for assessing the effects of concomitant variables in survival analysis.

31 December 2023

31

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

Tissue microarray sampling strategy for prostate cancer biomarker analysis

31 December 2023

32

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

Expression of E-cadherin in primary prostate cancer: correlation with clinical features

31 December 2023

34

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

Polycomb group protein complexes: do different complexes regulate distinct target genes?

31 December 2023

35

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

Characterization of interactions between the mammalian polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian polycomb-group protein complexes

31 December 2023

36

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

Soluble forms of the adhesion molecule E-cadherin in urine

31 December 2023

39

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

Truncation of the beta-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution

31 December 2023

42

1 reference

https://api.crossref.org/works/10.1093/JNCI/95.9.661

31 December 2023

Identifiers

1 reference

2 December 2017

1 reference